Webinar: Reducing Tax Risk for High-Growth Companies

If there’s one thing certain when it comes to tech companies and taxes, it’s that nobody likes surprises regarding risk in their business or investments. This couldn’t be truer than in high-growth companies that are embarking on a major expansion, approaching an IPO or acquisition, or evaluating some other exit strategy.

Bayer HealthCare starts its own accelerator – and it’s better than you expected

Bayer HealthCare appears to be the first pharmaceutical company to have started its own accelerator. The company that made €18.924 million in turnover in 2013 “understands that innovation and healthcare cannot only be driven by the industry but also needs creativity,” said Christian Ullrich, Head of Marketing & Sales IT at Bayer HealthCare yesterday.